Back to results
US 2019/0169208 A1Published application
Macrocycle kinase inhibitors
AssigneeTP Therapeutics, Inc.
InventorsJingrong Jean CUI, Yishan LI, Evan W. ROGERS, Dayong ZHAI, Jane UNG
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to certain macrocyclic kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same to treat disease.
Claims32
A compound of the formula I
- or a pharmaceutically acceptable salt thereof, wherein
- X1 and X2 are independently S, S(O), S(O)2, O or N(R10);
- R1 is H, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C10 aryl, —C(O)OR8 or —C(O)NR8R9;
- wherein each hydrogen atom in C1-C6 alkyl, C2-C6 alkenyl, C2C6 alkynyl, C3-C6 cycloalkyl and C6-C10 aryl is independently optionally substituted by deuterium, halogen, —OH, —CN, —OC1-C6 alkyl, —NH2, —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, NHC(O)C1-C6 alkyl, —N(C1-C6 alkyl)C(O)C1-C6 alkyl, —NHC(O)NH2, —NHC(O)NHC1-C6 alkyl, —N(C1-C6 alkyl)C(O)NH2, —N(C1-C6 alkyl)C(O)NHC1-C6 alkyl, —NHC(O)N(C1-C6 alkyl)2, N(C1C6 alkyl)C(O)N(C1-C6 alkyl)2, —NHC(O)OC1-C6 alkyl, —N(C1-C6 alkyl)C(O)OC1-C6 alkyl, —NHS(O)(C1-C6 alkyl), —NHS(O)2(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)(C1-C6 alkyl), N(C1C6 alkyl)S(O)2(C1-C6 alkyl), —NHS(O)NH2, —NHS(O)2NH2, —N(C1-C6 alkyl)S(O)NH2, N(C1-C6 alkyl)S(O)2NH2, —NHS(O)NH(C1-C6 alkyl), —NHS(O)2NH(C1-C6 alkyl), NHS(O)N(C1-C6 alkyl)2, —NHS(O)2N(C1-C6 alkyl)2, —N(C1-C6 alkyl)S(O)NH(C1-C6 alkyl), N(C1-C6 alkyl)S(O)2NH(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)N(C1-C6 alkyl)2, —N(C1-C6 alkyl)S(O)2N(C1-C6 alkyl)2, —CO2H, —C(O)OC1-C6 alkyl, —C(O)NH2, —C(O)NH(C1-C6 alkyl), C(O)N(C1-C6 alkyl)2, SC1-C6 alkyl, —S(O)C1-C6 alkyl, —S(O)2C1-C6 alkyl, S(O)NH(C1-C6 alkyl), —S(O)2NH(C1-C6 alkyl), —S(O)N(C1-C6 alkyl)2, —S(O)2N(C1-C6 alkyl)2, P(C1-C6 alkyl)2, —P(O)(C1-C6 alkyl)2, C3-C6 cycloalkyl, or 3- to 7-membered heterocycloalkyl;
- each R2 and R3 is independently H, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C10 aryl, —C(O)OR8 or —C(O)NR8R9;
- wherein each hydrogen atom in C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl and C6-C10 aryl is independently optionally substituted by deuterium, halogen, —OH, —CN, —OC1-C6 alkyl, —NH2, —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —NHC(O)C1-C6 alkyl, —N(C1-C6 alkyl)C(O)C1-C6 alkyl, —NHC(O)NH2, NHC(O)NHC1-C6 alkyl, —N(C1-C6 alkyl)C(O)NH2, —N(C1-C6 alkyl)C(O)NHC1-C6 alkyl, NHC(O)N(C1-C6 alkyl)2, —N(C1-C6 alkyl)C(O)N(C1-C6 alkyl)2, —NHC(O)OC1-C6 alkyl, N(C1C6 alkyl)C(O)OC1-C6 alkyl, —NHS(O)(C1-C6 alkyl), —NHS(O)2(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)2(C1-C6 alkyl), —NHS(O)NH2, —NHS(O)2NH2, N(C1C6 alkyl)S(O)NH2, —N(C1-C6 alkyl)S(O)2NH2, —NHS(O)NH(C1-C6 alkyl), NHS(O)2NH(C1-C6 alkyl), —NHS(O)N(C1-C6 alkyl)2, —NHS(O)2N(C1-C6 alkyl)2, —N(C1-C6 alkyl)S(O)NH(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)2NH(C1-C6 alkyl), —N(C1-C6 alkyl)S(O)N(C1C6 alkyl)2, —N(C1-C6 alkyl)S(O)2N(C1-C6 alkyl)2, —CO2H, —C(O)OC1-C6 alkyl, C(O)NH2, C(O)NH(C1-C6 alkyl), —C(O)N(C1-C6 alkyl)2, —SC1-C6 alkyl, —S(O)C1-C6 alkyl, —S(O)2C1-C6 alkyl, —S(O)NH(C1-C6 alkyl), —S(O)2NH(C1-C6 alkyl), —S(O)N(C1-C6 alkyl)2, —S(O)2N(C1-C6 alkyl)2, —P(C1-C6 alkyl)2, —P(O)(C1-C6 alkyl)2, C3-C6 cycloalkyl, or 3- to 7-membered heterocycloalkyl;
- or R2 and R3 taken together with the carbon atoms to which they are attached optionally form a C5-C7 cycloalkyl or a 5- to 7-membered heterocycloalkyl;
- or R2 and R6 taken together with the atoms to which they are attached optionally form a 5- to 7-membered heterocycloalkyl;
- R4 is H, C1-C6 alkyl or 3- to 7-membered heterocycloalkyl, wherein each hydrogen atom in C1-C6 alkyl or 3- to 7-membered heterocycloalkyl is independently optionally substituted by halogen, —OH, —CN, —OC1-C6 alkyl, —NH2, —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —CO2H, C(O)OC1C6 alkyl, —C(O)NH2, —C(O)NH(C1-C6 alkyl), —C(O)N(C1-C6 alkyl)2, C3-C6 cycloalkyl, or monocyclic 5- to 7-membered heterocycloalkyl;
- R5, R6 and R7 are each independently selected from the group consisting of H, fluoro, chloro, bromo, C1-C6 alkyl, —OH, —CN, OC1-C6 alkyl, —NHC1-C6 alkyl, —N(C1-C6 alkyl)2, C3-C6 cycloalkyl, 3- to 7-membered heterocycloalkyl, —O—(C3-C6 cycloalkyl), —O-(3- to 7-membered heterocycloalkyl), 5- to 7 membered heteroaryl, C6-C10 aryl, and CF3;
- wherein each hydrogen atom in C1-C6 alkyl, OC1-C6 alkyl, —NHC1-C6 alkyl, —N(C1-C6 alkyl)2, C3-C6 cycloalkyl, 3- to 7-membered heterocycloalkyl, —O—(C3-C6 cycloalkyl), —O-(3- to 7-membered heterocycloalkyl), 5- to 7 membered heteroaryl and C6-C10 aryl is independently optionally substituted by fluoro, chloro, bromo, —OH, CN, —OC1-C6 alkyl, —NH2, NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, C3-C7 cycloalkyl, 3- to 7-membered heterocycloalkyl, C6-C10 aryl, 5- to 7 membered heteroaryl, —CO2H, C(O)OC1C6 alkyl, C(O)NH2, —C(O)NH(C1-C6 alkyl) and —C(O)N(C1-C6 alkyl)2;
- each R8 and R9 is independently H, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, 3- to 7-membered heterocycloalkyl, C6-C10 aryl or heteroaryl;
- each R10 is independently H, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3C6 cycloalkyl, 3- to 7-membered heterocycloalkyl, C6-C10 aryl, or mono- or bicyclic heteroaryl;
- wherein each hydrogen atom in C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, 3- to 7-membered heterocycloalkyl, C6-C10 aryl, or mono- or bicyclic heteroaryl is independently optionally substituted by deuterium, halogen, C1-C6 alkyl, C1-C6 haloalkyl or —OR8;
- n is 1 or 2;
- and
- provided that at least one of R5 or R7 is not H, and provided that the compound is not of the formula
14 more elements
-3. (canceled)
(canceled)
-11. (canceled)
-20. (canceled)
-26. (canceled)
(canceled)
-33. (canceled)
(canceled)
-50. (canceled)
(canceled)
-61.
-83. (canceled)
Dependencies are inferred from the claim text.